BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35880673)

  • 1. Diagnosis and treatment of the rare procedural complication of malpositioned pacing leads in the left heart: a single center experience.
    Borgquist R; Farouq M; Markstad H; Brandt J; Mörtsell D; Jensen S; Chaudhry U; Wang L
    Scand Cardiovasc J; 2022 Dec; 56(1):302-309. PubMed ID: 35880673
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility and Safety of Percutaneous Lead Revision for Subacute and Delayed Cardiac Device Lead Perforation.
    Issa ZF; Issa TZ
    JACC Clin Electrophysiol; 2021 Jan; 7(1):26-35. PubMed ID: 33478709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors, and outcome of inadvertent malposition of transvenous pacing or defibrillation lead in the left heart.
    Ohlow MA; Roos M; Lauer B; Von Korn H; Geller JC
    Europace; 2016 Jul; 18(7):1049-54. PubMed ID: 26462705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
    Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of inadvertently placed pacing and ICD leads in the left ventricle: a multicenter experience and review of the literature.
    Van Gelder BM; Bracke FA; Oto A; Yildirir A; Haas PC; Seger JJ; Stainback RF; Botman KJ; Meijer A
    Pacing Clin Electrophysiol; 2000 May; 23(5):877-83. PubMed ID: 10833709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads.
    Migliore F; Zorzi A; Bertaglia E; Leoni L; Siciliano M; De Lazzari M; Ignatiuk B; Veronese M; Verlato R; Tarantini G; Iliceto S; Corrado D
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1602-9. PubMed ID: 25131984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Use of the Subcutaneous Implantable Cardioverter Defibrillator and a Permanent Pacemaker.
    Huang J; Patton KK; Prutkin JM
    Pacing Clin Electrophysiol; 2016 Nov; 39(11):1240-1245. PubMed ID: 27734502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead astray: minimally invasive removal of a pacing lead in the left ventricle.
    Stouffer CW; Shillingford MS; Miles WM; Conti JB; Beaver TM
    Clin Cardiol; 2010 Jun; 33(6):E109-10. PubMed ID: 20552628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parameters of cardiac pacing and effectiveness of defibrillation during implantable cardioverter-defibrillator lead implantation to right ventricle outflow tract].
    Rydlewska A; Machejek J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):254-8. PubMed ID: 24575643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy.
    Wang S; Wu S; Xu L; Xiao F; Whinnett ZI; Vijayaraman P; Su L; Huang W
    J Am Heart Assoc; 2019 Dec; 8(24):e014253. PubMed ID: 31830874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of subacute and delayed right ventricular perforation with a pacing or an implantable cardioverter-defibrillator lead.
    Laborderie J; Barandon L; Ploux S; Deplagne A; Mokrani B; Reuter S; Le Gal F; Jais P; Haissaguerre M; Clementy J; Bordachar P
    Am J Cardiol; 2008 Nov; 102(10):1352-5. PubMed ID: 18993154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful percutaneous extraction of malpositioned pacemaker lead in the left ventricle after proper dabigatran treatment.
    Farouq M; Borgquist R; Brandt J; Mörtsell D; Wang L
    Pacing Clin Electrophysiol; 2022 Sep; 45(9):1101-1105. PubMed ID: 35348211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation.
    Biffi M; Bertini M; Ziacchi M; Martignani C; Valzania C; Diemberger I; Branzi A; Boriani G
    Heart Vessels; 2009 Mar; 24(2):142-6. PubMed ID: 19337799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of lead failure in patients implanted with cardiac devices.
    Aizawa Y; Negishi M; Kashimura S; Nakajima K; Kunitomi A; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Fukumoto K; Tanimoto Y; Kohsaka S; Takatsuki S; Fukuda K
    Int J Cardiol; 2015 Nov; 199():277-81. PubMed ID: 26218183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of right ventricular pacing parameters in patients with proliferative scar.
    Vurgun VK; Baskovski E; Goksuluk H; Ozyuncu N; Tan TS; Altin AT; Candemir B; Akyurek O
    J Interv Card Electrophysiol; 2018 Nov; 53(2):249-254. PubMed ID: 29948585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads.
    Cano Ó; Andrés A; Alonso P; Osca J; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L
    Europace; 2017 Jan; 19(1):96-102. PubMed ID: 26847075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate shock delivery and biventricular pacing cardiac defibrillators.
    Liu BC; Villareal RP; Hariharan R; Rasekh A; Massumi A
    Tex Heart Inst J; 2003; 30(1):45-9. PubMed ID: 12638671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.